Z. Mazor - Concepedia

Author

Z. Mazor

Also Known As

Z Mazor, Z. MAZOR, Z. Mazor, Ze?ev Mazor

Publications

241

Citations

H-Index

Concepts

All Affiliations

Z. Mazor is an author at Teva Pharmaceuticals (Israel) specializing in medicine, fall prevention, and osteoporosis.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	217
2	Health Sciences	2	2	123
3	Applied Physiology	1	1	78
4	Clinical Nutrition	1	1	45
5	Geriatrics	1	1	78

Z. Mazor

Publications

236

Citations

H-Index

Page 1

	Year	Citations
A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65�ml/min Laurent Dukas, E. Schacht, Z. Mazor, Osteoporosis International Fall PreventionElderly MenPhysical ActivityGeriatricsLow Creatinine Clearance	2004	78
Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with a low creatinine clearance of <65�ml/min Laurent Dukas, E. Schacht, Z. Mazor, Osteoporosis International Fall PreventionElderly PeopleLow Creatinine ClearanceGeriatric Fracture CarePharmacotherapy	2004	53
Alfacalcidol (Alpha D3) and Calcium in Osteoporosis J. Menczel, J. Földes, R. Steinberg, Clinical Orthopaedics and Related Research Calcium 500NutritionUrologyBone HealthOrthopaedic Surgery	1994	45
Piloplex, a new long-acting pilocarpine polymer salt. B: Comparative study of the visual effects of pilocarpine and Piloplex eye drops. Z. Mazor, U Ticho, Uri Rehany, British Journal of Ophthalmology OptogeneticsYoung Healthy VolunteersDouble Blind StudyOcular DiseaseOphthalmology	1979	41
Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass. Dieter Felsenberg, Oliver Bock, H. G. Borst, PubMed	2011	19

Page 1